A systematic review of symptom assessment scales in children with cancer

BMC Cancer

Table 1 Characteristics of studies that used a symptom assessment scale in pediatric oncology

Author	Year	Instrument	Mean age in years ± SD or (range)	Number enrolled	Respondent	Timing **	Once or multiple ***
Baggott[18]	2011	MSAS 10-18	14.7 ± 2.8	66	Child	During	Multiple
Wu[19]	2011	SDS	NS	40	Child	During	Once
Gibson[16]	2010	ASyMS-YG	15* (13–18)	27	Child	During	Multiple
Poder[3]	2010	MSAS 10-18	NS	292	Parent	During	Multiple
Walker[20]	2010	MSAS 7-12	14.2 + 2.7	51	Child	During	Multiple
Dupuis[17]	2009	Unique	9.4 ± 6.8	200	Parent	During	Once
Sitaresmi[21]	2009	Unique	6* (2–16)	61	Parent	During	Once
Yeh[22]	2009	MSAS 10-18	14.2 + 2.2	144	Parent	Both	Once
Williams[23]	2006	TRSC-C	10.4 ± 6.1	11	Parent	During	Once
Collins[24]	2002	MSAS 7-12	9.6 (7–12)	149	Child	Both	Multiple
Hinds[25]	2002	SDS	15.5 ± 2.1	77	Child	During	Multiple
Collins[26]	2000	MSAS 10-18	14 (10–18.2)	160	Child	Both	Multiple
Berard[27]	1998	RSCL	16.9	43	Child	During	Multiple
Eiser[28]	1997	RSCL	14.5 (4–19)	47	Parent	Both	Once

*Median; **Timing refers to whether instrument was administered during active treatment only or both during and following completion of chemotherapy; ***Instrument administered once or more than once.
Abbreviations: ASyMS-YG Advanced Symptom Management System – Young, MSAS Memorial Symptom Assessment Scale, SDS Symptom Distress Scale, TRS-C Therapy-related Symptom Checklist, RSCL Rotterdam Symptom Checklist, SD standard deviation, NS not stated.

ISSN: 1471-2407